Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of osteopenia and incidence of fragility fracture in adult patients with gastrointestinal cancer: protocol for a systematic review and meta-analysis.

BMJ open·2026
Same author

Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-study of the LOVIT Trial.

Clinical pharmacokinetics·2026
Same author

Performance of Survival Prediction Tools in Patients With Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis.

Journal of surgical oncology·2026
Same author

Differences in admission to trauma centres by sex among adults with traumatic brain injury: a population-based cohort study.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis.

Intensive care medicine experimental·2026
Same author

Effects of antibiotic treatment on clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

The Lancet. Microbe·2026

Related Experiment Video

Updated: Jul 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins, bugs and prophylaxis: intriguing possibilities.

Marius Terblanche1, Terry S Smith, Neill K J Adhikari

  • 1Department of Critical Care Medicine, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. marius.terblanche@icunet.org

Critical Care (London, England)
|November 11, 2006
PubMed
Summary

Statin therapy shows promise as a preventive treatment for high-risk individuals, particularly during pandemic influenza or intensive medical care. Emerging research supports its potential prophylactic use in these vulnerable populations.

Related Experiment Videos

Last Updated: Jul 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Pharmacology and Infectious Disease Management

Background:

  • Statin therapy is widely used for cholesterol management.
  • Certain high-risk scenarios may benefit from prophylactic interventions.

Purpose of the Study:

  • To explore the potential prophylactic role of statin therapy.
  • To identify high-risk groups where statins could be beneficial.

Main Methods:

  • Review of emerging data and clinical evidence.
  • Analysis of statin's potential in specific high-risk conditions.

Main Results:

  • Emerging data suggest a potential prophylactic role for statins.
  • High-risk scenarios include pandemic influenza and aggressive medical treatments.

Conclusions:

  • Statin therapy may offer a prophylactic benefit in select high-risk populations.
  • Further research is warranted to confirm the prophylactic efficacy of statins in these contexts.